Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse

(2019) Willem Sebastiaan van Hoogstraten et al.   JOURNAL OF HEADACHE AND PAIN

Erenumab in chronic migraine with medication overuse

(2019) Stewart J. Tepper et al.   NEUROLOGY

Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache

(2019) Caroline M Kopruszinski et al.   CEPHALALGIA

CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice

(2019) Edita Navratilova et al.   CEPHALALGIA

Whatʼs New in the Treatment of Migraine?

(2019) Kathleen B. Digre   JOURNAL OF NEURO-OPHTHALMOLOGY

Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine

(2019) Richard B. Lipton et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system

(2019) Jacob C. A. Edvinsson et al.   JOURNAL OF HEADACHE AND PAIN

Ubrogepant for the Treatment of Migraine

(2019) David W. Dodick et al.   NEW ENGLAND JOURNAL OF MEDICINE

CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine

(2018) Heike Israel et al.   Current Pain and Headache Reports

Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study

(2018) Todd J. Schwedt et al.   JOURNAL OF HEADACHE AND PAIN

International Classification of Headache Disorders

(2018) Jes Olesen   LANCET NEUROLOGY

Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients

(2018) Licia Grazzi et al.   Current Pain and Headache Reports

History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment

(2018) Stewart J. Tepper   HEADACHE

Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache

(2018) Kelsey M Nation et al.   CEPHALALGIA

Early onset of efficacy with erenumab in patients with episodic and chronic migraine

(2018) Todd Schwedt et al.   JOURNAL OF HEADACHE AND PAIN

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Spencer L James et al.   LANCET

Delta opioid receptor agonists are effective for multiple types of headache disorders

(2018) Laura S. Moye et al.   NEUROPHARMACOLOGY

The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine

(2017) Lars Edvinsson   HEADACHE

Activation of dura-sensitive trigeminal neurons and increased c-Fos protein induced by morphine withdrawal in the rostral ventromedial medulla

(2016) Suzuro Hitomi et al.   CEPHALALGIA

Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents

(2016) Caroline Machado Kopruszinski et al.   CEPHALALGIA

Risk of medication overuse headache across classes of treatments for acute migraine

(2016) Kristian Thorlund et al.   JOURNAL OF HEADACHE AND PAIN

Chronic migraine with medication overuse: Association between disability and quality of life measures, and impact of disease on patients' lives

(2015) Alberto Raggi et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Medication Overuse Headache

(2014) Valerie Cheung et al.   Current Neurology and Neuroscience Reports

General trigeminospinal central sensitization and impaired descending pain inhibitory controls contribute to migraine progression

(2014) Nelly Boyer et al.   PAIN

Differences in Clinical Features and Disability according to the Frequency of Medication Use in Patients with Chronic Migraine

(2012) Gyoung Im Suh et al.   Journal of Clinical Neurology

Epidemiology of medication overuse headache in the general Swedish population

(2011) Pernilla Jonsson et al.   CEPHALALGIA

Selective Inhibition of 5-HT7Receptor Reduces CGRP Release in an Experimental Model for Migraine

(2010) Xiaojuan Wang et al.   HEADACHE

Prevalence of Secondary Chronic Headaches in a Population-Based Sample of 30-44-Year-Old Persons. The Akershus Study of Chronic Headache

(2008) K Aaseth et al.   CEPHALALGIA

Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner

(2008) Xu Yue et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population-Based Study

(2008) Marcelo E. Bigal et al.   HEADACHE